Position in CYTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$65,418,640
+$65,418,640 QoQ
Shares Held
992,545
Ownership
0.798%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Mar 31, 2026CallValue
$6,960,096
CallShares
105,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $2,162,763,632 across 176 Biotechnology names. CYTK ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,779,445 | $146,532,340 | |
| 2 | ERAS |
Erasca, Inc.
|
5,143,985 | $83,229,677 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
3,826,659 | $80,053,706 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,917,501 | $77,141,065 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,362,752 | $76,981,860 | |
| 6 | CYTK |
Cytokinetics Inc
This page
|
992,545 | $65,418,640 | |
| 7 | DAWN |
Day One Biopharmaceuticals, Inc.
|
2,625,235 | $56,285,038 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,827,513 | $55,345,837 |
All Filings in CYTK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,960,096 | 105,600 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $65,418,640 | 992,545 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,779,090 | 358,500 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $19,818,576 | 360,600 | Call | Sole | 2025-11-14 | |
| 2024-09-30 | $248,160 | 4,700 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $6,203,313 | 117,487 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,582,064 | 601,367 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $10,895,598 | 201,100 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $17,604,621 | 251,100 | Call | Sole | 2024-05-13 | |
| 2024-03-31 | $47,328,596 | 675,062 | Shares | Other | 2024-05-13 | |
| 2024-03-31 | $10,642,698 | 151,800 | Put | Sole | 2024-05-13 | |
| 2023-12-31 | $5,259,870 | 63,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $34,492,808 | 413,137 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $28,394,949 | 340,100 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $1,334,538 | 45,300 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $34,729,745 | 1,178,878 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $34,953,373 | 1,071,532 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $33,501,020 | 952,004 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,386,114 | 881,408 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,723,364 | 283,248 | Shares | Other | 2022-11-15 | |
| 2022-06-30 | $7,411,626 | 188,639 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $451,743 | 9,911 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,319,342 | 36,915 | Shares | Sole | 2021-12-01 | |
| 2020-09-30 | $866,000 | 40,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $2,712,701 | 125,298 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||